Biodistribution of Radiolabeled Cramoll 1,4
Author Information
Author(s): Beatriz Ferreira de Carvalho Patricio, Maria Helena Madruga Lima-Ribeiro, Maria Tereza dos Santos Correia, Ana Maria dos Anjos Carneiro-Leão, Marta de Souza Albernaz, Thiago Barboza, Sergio Augusto Lopes de Souza, Ralph Santos-Oliveira
Primary Institution: Laboratory of Nanoradiopharmaceuticals, Academical Hospital Clementino Fraga Filho
Hypothesis
What is the biodistribution of Cramoll 1,4 when radiolabeled with Tc-99m?
Conclusion
The study found that Cramoll 1,4 has an unusual clearance mechanism, particularly with abnormal uptake in the bowel.
Supporting Evidence
- The study used thin-layer chromatography to confirm the successful labeling of Cramoll 1,4.
- Significant accumulation of the lectin was observed in the bowel, which was unexpected.
- The lectin was processed primarily by the liver, which is typical for injectable drugs.
- The study protocol was approved by the Institutional Review Board and the Animal Ethics Committee.
Takeaway
The researchers used a special technique to track a protein in rats and found it acted differently than expected, especially in the intestines.
Methodology
Cramoll 1,4 was radiolabeled with Tc-99m and its biodistribution was evaluated in a male Wistar rat.
Limitations
The study was conducted on a single male rat, which limits the generalizability of the findings.
Participant Demographics
One male Wistar rat was used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website